Back

Hypochloremia in chronic and acute heart failure scenarios: prevalence and risk factors

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Novel risk factors and AI-enhanced prognostic strategies in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Pau Llacer

Ramon and Cajal University Hospital, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail
Heart failure prevalence and incidence in Germany: insights in ambulatory drug therapy and comorbidities
Mr D. Jurczyk (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Metformin associated lower risk of dementia among heart failure patients: a population-based retrospective cohort study
Miss A. Matsumoto (HK)
Abstract Slides Video
Presentation thumbnail
Deep learning by vision transformer based assessment of image quality in echocardiography improves prediction of heart failure specific outcome
Ms A. Romano Martinez (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Impact of coronavirus disease 19 (COVID-19) pandemic on age differences of heart failure with reduced ejection fraction (HFrEF) admissions and in-hospital outcomes
Doctor A. Ceka (Tirana, AL)
Abstract Slides Video
Presentation thumbnail
Impact of recovery of vital signs after a 6-minute walk test over mortality in right heart failure patients.
Doctor C. Chavez Guzman (Mexico City, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Novel risk factors and AI-enhanced prognostic strategies in heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Chloride: an emergent biomarker with prognostic significance in acute cardiorenal syndrome
thumbnail
Congress Presentation
Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study
thumbnail
Congress Presentation
Early spot urinary chloride as a predictor of mortality in acute heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources